Searchable abstracts of presentations at key conferences in endocrinology

ea0081p238 | Thyroid | ECE2022

The use of body composition measured by CUN-BAE as a simple tool to predict the LT4 titration after total thyroidectomy in patients with benign and malignant thyroid disease

Maria Diaz Abram Ana , Chumbiauca Estefania , Carlos Galofre Juan

Background: Patients who require levothyroxine (LT4) supplementation after total thyroidectomy often have difficulty achieving target TSH levels. Several studies have attempted to develop a dosing schedule considering different factors such as age, gender, weight, or body mass index (BMI) as potential determinants of the correct dose of LT4. The objective of this study is to determine if a scheme that uses the percentage of body fat (%BF) measured by CUN-BAE is more accurate t...

ea0028p131 | Cytokines and growth factors | SFEBES2012

Effects of long-term intermittent administration of GH on EGF signaling in liver

Diaz Maria , Miquet Johanna , Sotelo Ana , Turyn Daniel , Gonzalez Lorena

Growth hormone (GH) is involved in body growth and metabolism. This hormone is used for the treatment of various clinical conditions and is administrated subcutaneously once daily or 3 times a week. The chronic use of GH has side effects; among them, the increase in tumor incidence. GH activates pathways related with oncogenesis not only by the activation of its specific receptor, but also by transactivation and regulation of the expression of the epidermal growth factor recep...

ea0056p1178 | Thyroid cancer | ECE2018

Malignancy risk stratification of thyroid nodules with cytological diagnosis of folicular neoplasm (Bethesda IV), according to the ultrasound sonographic patterns proposed by the American Thyroid Association (ATA)

Pineda Jose Javier , Ernaga Ander , Anda Emma , Toni Marta , Martinez Juan Pablo , Munarriz Patricia , Rojo Jorge , Ollero Dolores , Diaz Maria

Background: The main limitation of fine-needle aspiration (FNA) is represented by indeterminate category (Bethesda III and IV) in which the risk of malignancy is between 5-30%. Given this result, surgical treatment is necessary in many cases. The aim of our study is to assess whether the ultrasound patterns proposed by the ATA, help us to stratify the risk of malignancy in nodules with Bethesda IV cytology result.Methods: From January 2011 to June 2017 w...

ea0063p105 | Calcium and Bone 1 | ECE2019

Parathyroid carcinoma: identity with diagnostic difficulties and therapeutic strategies

Maria Diaz Perdigones Cristina , Maria Gomez Perez Ana , Maria Cornejo Pareja Isabel , Munoz Garach Araceli , Damas Fuentes Miguel , Molina Vega Maria , Maraver Selfa Silvia

Blackground: Parathyroid carcinoma is a malignant neoplasm affecting 0.5 to 5.0% of all patients suffering from primary hyperparathyroidism. This cancer continues to cause challenges for diagnosis and treatment because of its rarity, overlapping features with benign parathyroid disease.Case report: 50 years-old-woman, without relevant previous history. She begins to present asthenia, weakness of lower limbs, arthralgias, cramps and appearance of a painfu...

ea0063p622 | Diabetes, Obesity and Metabolism 2 | ECE2019

Assessment of materno-fetal complications in pregnant women with type 1 diabetes exposed to insulin degludec

Martinez Montoro Jose Ignacio , Hernandez Garcia Carmen , Jose Picon Cesar Maria , Molina Vega Maria , Maria Diaz Perdigones Cristina , Damas Fuentes Miguel , Jose Tinahones Madueno Francisco

Introduction: Pregnancy in women with type 1 diabetes mellitus (T1DM) is associated with an increased risk of adverse outcomes, so pregnancy planning in order to achieve an optimal glycemic control is essential. This control has been made possible, in part, by the widespread use of insulin analogues, especially the long-acting ones, glargine and detemir. Insulin degludec, an ultra-long-acting insulin is not currently approved for pregnant women due to the lack of randomized co...

ea0056p16 | Adrenal cortex (to include Cushing's) | ECE2018

Rare incidence of primary adrenocortical carcinosarcoma: a case report

Maria Diaz Perdigones Cristina , Maria Cornejo Pareja Isabel , Damas Fuentes Miguel , Molina Vega Maria , Hernandez Garcia Carmen , Munoz Garach Araceli , Jose Tinahones Madueno Francisco

Introduction: Adrenal tumors are common tumors with a prevalence of around 3% in a population over the age of 50 years. In contrast, adrenocortical carcinoma (ACC) is a rare malignancy (incidence 1–2 per 1 million population) with a heterogeneous presentation and a variable but generally bad prognosis. Patients present with evidence of adrenal steroid hormone excess in approximately 60% of cases.Case report: A 49-year-old woman with symptoms of faci...

ea0056p299 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice

Garcia Carmen Hernandez , Perdigones Cristina Maria Diaz , Fuentes Miguel Damas , Martinez Clara Estaun , Ramos Andrea Sanchez , Ramos Ana Molina , Madueno Francisco Tinahones

Introduction and objectives: The treatment with monoclonal antibodies that inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9) is a new group of drugs that allows us to reach the therapeutic targets of low density cholesterol (LDL-c) in patients intolerant to statins or those who despite treatment with maximum doses of them do not obtain a proper lipid control.Material and methods: We performed a descriptive observational study. We include all ...

ea0056p361 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Phenotypic and autoimmunity analysis of patients with type 1 diabetes mellitus onset

Maria Diaz Perdigones Cristina , Hern Carmen , Damas Fuentes Miguel , Jose Picon Cesar Maria , Luis Pinzon Martin Jose , Molina Vega Maria , Tinahones Madueno Francisco

Introduction: Type 1 diabetes mellitus (T1DM) is considered, in general, a disease of children and young adults with normal body mass index (BMI), linked to a genetic susceptibility based on autoimmunity. However, we know that it can be diagnosed at any age and we must differentiate it from type 2 diabetes mellitus.Objetives: To investigate the phenotypic characteristics and the presence of specific autoimmunity in T1DM patients diagnosed in our hospital...

ea0037ep1253 | Clinical Cases–Thyroid/Other | ECE2015

Squamous cell thyroid carcinoma, the importance of early diagnosis and treatment

Cornejo-Pareja Isabel M , Maraver-Selfa Silvia , Garcia-Aleman Jorge , Ortega-Jimenez M Victoria , Munoz-Garach Araceli , Gomez-Perez Ana M , Molina-Vega Maria , Diaz-Perdigones Cristina , Mancha-Doblas Isabel , Tinahones-Madueno Francisco Jose

Introduction: Squamous cell thyroid carcinoma is a very rare malignant epithelial tumour. It presents as rapid growth cervical mass, may affect neighbour structures and sometimes metastasizes other parts of the body. It’s often associated with previous goiter history and occasionally with autoimmune thyroiditis. It can appear pure, as a component of undifferentiated carcinoma, or combined with differentiated carcinoma areas (papillary or follicular).<p class="abstext"...

ea0037ep1262 | Clinical Cases–Thyroid/Other | ECE2015

New treatments of diabetes: a promising alternative to bariatric surgery in obese patients

Roca-Rodriguez M Mar , Mancha-Doblas Isabel , Picon-Cesar M Jose , Gomez-Perez Ana Maria , Cornejo-Pareja Isabel , Molina-Vega Maria , Diaz-Perdigones Cristina , Olveira-Fuster Gabriel , Tinahones Francisco J

Introduction: New treatments of diabetes improve global metabolic status beyond glycemic control and achieve weight reduction in many patients.Case reports: We described four case reports to show GLP-1 agonists and dapaglifozin effects on metabolism and weight in patients with type 2 diabetes and obesity.Case 1 (Liraglutide): A 48-year-old man, hypertension, type 2 diabetes and extreme obesity. Baseline visit: treatment enalapril 2...